Skip to main content
Clinical Trials/IRCT20230714058776N1
IRCT20230714058776N1
Completed
N/A

The Effect of ShotBlocker in Reducing Pain Associated with Peripheral Intravenous Cannulation in School Age Children: A Randomized Controlled Trial (RCT)

College of Nursing, University of Baghdad0 sites128 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain management related intravenous cannulation.
Sponsor
College of Nursing, University of Baghdad
Enrollment
128
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
College of Nursing, University of Baghdad

Eligibility Criteria

Inclusion Criteria

  • Consent to volunteer to participate in the study.
  • Being between the ages of 6 and 12 years.
  • Intravenous cannulation will be applied in right and left hand only.
  • No difficulty in communication, including hearing, visual, speech, and language problems.
  • Not receiving oral or parenteral analgesic treatment before administration.
  • Not receiving chemotherapy treatment.

Exclusion Criteria

  • Skin conditions such as burns, rashes, open wounds, abscess or boil, severe local infection or cellulitis at the intended insertion site.
  • Peripheral vascular disease or compromised peripheral circulation at the intended insertion site (e. g. Peripheral neuropathy, diabetes, Peripheral artery disease, Raynaud's disease).
  • Blood clotting disorders or increased risk of bleeding (e.g., hemophilia, thrombocytopenia).
  • Anatomical abnormalities or restrictions that impede proper insertion or cause increased risk of complications.
  • History of injections during the last 3 months.

Outcomes

Primary Outcomes

Not specified

Similar Trials